• Profile
Close

Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis

Journal of Bone and Mineral Research Feb 01, 2019

Beek KJ, et al. - In patients with ankylosing spondylitis (AS), researchers assessed the long term effects of TNF-inhibitors (TNFi) on bone mineral density (BMD) and the incidence of vertebral fractures (VFx). For this investigation, they involved consecutive patients with active AS with TNFi treatment duration up to 4 years with available DXA scans and spine X-rays. A total of 135 AS patients were included. Despite improving BMD and a well-known decrease in disease activity, investigators still found new VFx, an increase in the number and grade of VFx and radiographic progression during 4 years of TNFi treatment in long-term AS patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay